| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. | Chief Legal Officer | Stock option (right to buy) | 295,000 | $1,684,450 | $5.71 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | 30 Jan 2026 | 1 | +$1,684,450 | 4 | Chief Legal Officer | 02 Feb 2026, 16:03 |
| FHTX | Foghorn Therapeutics Inc. | 22 Jan 2025 | 1 | +$550,620 | 4 | Chief Legal Officer | 24 Jan 2025, 16:06 |
| FHTX | Foghorn Therapeutics Inc. | 24 Jan 2024 | 1 | +$306,000 | 4 | Chief Legal Officer | 25 Jan 2024, 16:01 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jan 2023 | 1 | $0 | 4 | Chief Legal Officer | 30 Jan 2023, 16:03 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jan 2022 | 1 | $0 | 4 | Chief Legal Officer | 28 Jan 2022, 15:26 |